- Research works
- 72 ▼ 8% vs 2013–17
- Citations
- 672 9.4 per fractional work
- Top-10% rate
- 17.1% record average 16.5%
- Open access
- 39% world 28%
Not ranked overall: Jiangsu Nhwa Pharmaceutical (China) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 9.6×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 9.6×
- Neuroscience 7.0×
- Immunology and Microbiology 4.2×
- Veterinary 3.8×
- Biochemistry, Genetics and Molecular Biology 3.0×
- Chemistry 2.8×
- Energy 1.7×
- Medicine 1.6×
- Materials Science 1.2×
- Health Professions 1.2×
- Engineering 0.8×
- Nursing 0.8×
- Physics and Astronomy 0.7×
- Computer Science 0.4×
- Earth and Planetary Sciences 0.3×
- Agricultural and Biological Sciences 0.2×
- Environmental Science 0.2×
- Social Sciences 0.0×
Which keywords describe research at Jiangsu Nhwa Pharmaceutical (China)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Depression, Oxidative Stress, Synaptic Plasticity, Drug Discovery, Pharmacology, Antiretroviral Therapy, Schizophrenia and Inflammation.
- Schizophrenia
- Pharmacology
- Synaptic Plasticity
- Oxidative Stress
- Depression
- Inflammation
- Drug Discovery
- Antiretroviral Therapy
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 8 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 8 words, with their numbers
- Depression3▲ 14×6 topics
- Oxidative Stress2▲ 5.7×11 topics
- Inflammation2▲ 3.3×10 topics
- Synaptic Plasticity1▲ 30×4 topics
- Drug Discovery1▲ 24×3 topics
- Pharmacology1▲ 20×3 topics
- Antiretroviral Therapy1▲ 30×5 topics
- Schizophrenia1▲ 44×3 topics
Which research topics does Jiangsu Nhwa Pharmaceutical (China) publish most on?
By volume in 2022–2025: Treatment of Major Depression, Receptor Mechanisms and Signaling, Tryptophan and brain disorders and Computational Drug Discovery Methods.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Treatment of Major Depression Pharmacology 1 works
- 2 Receptor Mechanisms and Signaling Molecular Biology 1 works
- 3 Tryptophan and brain disorders Biological Psychiatry 1 works
- 4 Computational Drug Discovery Methods Computational Theory and Mathematics 0 works
- 5 Acupuncture Treatment Research Studies Complementary and alternative medicine 0 works
- 6 Neurotransmitter Receptor Influence on Behavior Cellular and Molecular Neuroscience 0 works
- 7 Pharmacological Receptor Mechanisms and Effects Molecular Biology 0 works
- 8 HIV/AIDS drug development and treatment Infectious Diseases 0 works
- 9 Surface Roughness and Optical Measurements Computational Mechanics 0 works
- 10 Physical Education and Training Studies Physical Therapy, Sports Therapy and Rehabilitation 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Jiangsu Nhwa Pharmaceutical (China)'s research output changed?
Output in 2018–2022 was 8% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Xuzhou
- Xuzhou Medical College
- Jiangsu Normal University
- Affiliated Hospital of Xuzhou Medical College
- Xuzhou Children Hospital
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.